5 completed, 2 unknown. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow EGCG: new trials by email Literature Review of EGCG trials Research Report on EGCG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients EGCG - Interstitial Pneumonia, Neoplasms Malignant | Phase 1 / Phase 2 | Unknown | Shandong Cancer Hospital and Institute | 78 | 2023-01-05 | 2023-05-30 |
| Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer EGCG - Esophageal Obstruction | Phase 1 | Completed | Shandong Cancer Hospital and Institute | 18 | 2021-08-20 | 2024-04-03 |
| Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis EGCG - Epigallocatechin Gallate, Radio Dermatitis | Phase 1 / Phase 2 | Unknown | Shandong Cancer Hospital and Institute | 15 | 2011-09-01 | 2020-04-28 |
| Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals Polyphenon E, Placebo - HIV Infection | Phase 1 | Completed | Baylor College of Medicine | 23 | 2010-12-01 | 2023-05-19 |
| Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck Erlotinib, Green Tea Polyphenon E - Cancer of Head and Neck, Neoplasms, Head and Neck | Phase 1 | Completed | Emory University | 25 | 2010-03-01 | 2018-12-05 |
| Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C silymarin, green tea extract (EGCG) - Chronic Hepatitis C, Oxidative Stress | Phase 1 | Completed | University of North Carolina, Chapel Hill | 28 | 2009-11-01 | 2017-04-18 |
| Safety of Polyphenon E in Multiple Sclerosis Pilot Study Polyphenon E - Multiple Sclerosis | Phase 1 | Completed | Louisiana State University Health Sciences Center in New Orleans | 10 | 2009-02-01 | 2013-06-27 |
Airway Obstruction (1) · HIV Infections (1) · Head and Neck Neoplasms (1) · Hepatitis C, Chronic (1) · Lung Diseases, Interstitial (1) · Multiple Sclerosis (1) · Neoplasms (1)
Shandong Cancer Hospital and Institute (3) · Baylor College of Medicine (1) · Emory University (1) · Louisiana State University Health Sciences Center in New Orleans (1) · University of North Carolina, Chapel Hill (1)
United States (4) · China (2)
Dong M. Shin, MD (1) · Filiz Seeborg, MD, MPH (1) · Jesus F Lovera, MD, MSPH (1) · Jinming Yu, M.D. (1) · Ligang Xing, MD, PhD (1) · Michael W Fried, MD (1) · Roberto Arduino, MD (1) · Roy L Hawke, PhD, PharmD (1)
PMID 24444526, PMID 26298797, PMID 38632501
K23AT004433 (1), P50CA128613 (1), R21AT003892 (1), R21AT004673 (1)